AMR news related to Smart Innovations

For Scientists, Researchers and Innovating Professionals who want to stay adequately informed on Antimicrobial resistance, AMR Insights offers the most comprehensive overview of recently published, global news and information.


18 February 2021

Global Principles on Incentivizing Antibiotic R&D

18 February 2021

The AMR Action Fund announces its first non-industry investments, raising an additional US$140 million toward addressing antimicrobial resistance (AMR)

18 February 2021

The AMR Action Fund announces appointment of CEO, Henry B. Skinner, PhD

17 February 2021

Adaptive Phage Therapeutics Announces FDA Clearance of IND Application for PhageBank™ for the Treatment of Prosthetic Joint Infections

13 February 2021

GARDP welcomes additional funding from UK to develop new treatment for gonorrhoea

11 February 2021

Antibiotic stewardship in direct-to-consumer telemedicine consultations lead to high adherence to best practice guidelines and a low prescription rate

4 February 2021

CARB-X is funding French biotech Mutabilis to develop a new class of antibacterials to treat infections caused by carbapenem-resistant Enterobacterales

2 February 2021

CARB-X is funding the development of avails medical’s rapid antibiotic susceptibility testing technology

29 January 2021

Antimicrobial-specific response from resistance gene carriers studied in a natural, highly diverse microbiome

28 January 2021

The state of bioinformatics in the fight against AMR

26 January 2021

Singapore designs tool to investigate hospital borne bacterial infections

23 January 2021

Exploring Prediction of Antimicrobial Resistance Based on Protein Solvent Accessibility Variation

22 January 2021

Bacteriophage Therapy Market Update 2021

22 January 2021

Phage therapy offers hope in fight against antibiotic resistance and superbugs

22 January 2021

Irish soil can offer more hope in fight against antibiotic resistance, researchers show

22 January 2021

Letter: A better way to spend Ineos’ Oxford gift

22 January 2021

Fast-tracking the use of copper in the NHS to tackle AMR

19 January 2021

Ineos gives Oxford £100m to set up antibiotic research institute

18 January 2021

Taiwan develops microfluidic platform for rapid screening of diseases

18 January 2021

Research uncovers strategy to revert antibiotic-resistance in dangerous superbugs

18 January 2021

A framework for identifying the recent origins of mobile antibiotic resistance genes

18 January 2021

A two-pronged attack on antibiotic-resistant microbes

14 January 2021

Monash University leads breakthrough against antibiotic-resistance

7 January 2021

Five Things To Know About The Antifungal Drug Pipeline

7 January 2021

New Antimicrobial Resistance Centre will tackle humanity’s greatest threat

7 January 2021

Incentivizing antibiotic access and innovation

24 December 2020

In vitro assessment of antimicrobial resistance dissemination dynamics during multidrug resistant bacteria invasion events using a continuous culture device

24 December 2020

New class of antibiotics active against a wide range of bacteria

23 December 2020

Cloud-Based Informatics Enable Smarter Antibiotic Use and Infection Control

23 December 2020

First antimicrobial drugs purchased via new ‘subscription’ payment model

19 December 2020

How the ‘NHS model’ to tackle antimicrobial resistance (AMR) can set a global standard

19 December 2020

Leading Biomedical industry and Research-Based Groups Launch Coalition against Antimicrobial Resistance

19 December 2020

High-throughput laboratory evolution reveals evolutionary constraints in Escherichia coli

18 December 2020

COVID and AMR: Crisis Reframes Antibiotics Fight

15 December 2020

Can breastfeeding protect against antimicrobial resistance?

12 December 2020

Unbiased antimicrobial resistance detection from clinical bacterial isolates using proteomics

10 December 2020

Photonics21: EU needs to invest more in photonics now to fight future infectious diseases and pandemics

10 December 2020

Reimbursement models to tackle market failures for antimicrobials: Approaches taken in France, Germany, Sweden, the United Kingdom, and the United States

10 December 2020

Congressmen Doyle & Ferguson introduce Pasteur Act to promote new antimicrobial drugs

8 December 2020

Non-profits fill gaps in the broken market for antibiotics

7 December 2020

Investigating the role of the human phageome in relation to AMR

5 December 2020

C-CAMP, IHMA to develop innovative solutions for combating AMR

5 December 2020

Researchers Engineer Lysins to Target Bacteria With Surgical Precision

2 December 2020

Researchers develop customized targeting of bacteria using lysins

2 December 2020

GARDP, FIND and WHO Agree to Explore Joint Initiatives That Could Help Combat Antimicrobial Resistance

2 December 2020

CARB-X IS FUNDING A TEAM OF TOP GERMAN RESEARCHERS TO DEVELOP A DRUG TO TREAT STAPHYLOCOCCUS AUREUS INFECTIONS AND PREVENT EXACERBATION OF LIFE-THREATENING PNEUMONIA

8 November 2020

DESIGNING TOOLS FOR REAL WORLD IMPACT: USING MACHINE LEARNING TO PERSONALIZE ANTIBIOTIC TREATMENT

4 November 2020

Researchers find new lead for disarming antibiotic-resistant bacteria

3 November 2020

Emerging paradigm against global antimicrobial resistance via bioprospecting of mushroom into novel nanotherapeutics development

3 November 2020

The internet of things for combatting antimicrobial resistance



What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed